UCSF study of HIV patients identifies interleukin-7 as a key factor in controlling T-cells. “Researchers at the Gladstone Institute of Virology and Immunology have learned how T-cell levels may be maintained in
people. The study has important implications for developing treatment strategies for patients who have diseases like HIV and
cancer where the immune system is destroyed and for patients whose immune system is suppressed by chemotherapy or who
are undergoing a bone marrow transplant, the researchers said.” EurekAlert